03.11.25 -- UTSA Chemist To Advance Drug Discovery Using Light To Activate Catalysts

Avoid supply chain pitfalls in drug development by ensuring proper thermal shipping, real-time temperature monitoring, and choosing a reliable CDMO for efficiency, compliance, and product integrity.

Here, we discuss the challenges and solutions for cell and gene therapies, focusing on performance, scalability, and regulatory compliance to accelerate commercialization and improve patient access.

Delve into the intricate workflow employed for the discovery and characterization of monoclonal antibodies (mAbs) targeting the Delta spike protein.

Darryl Souness, Head of Analytical at Cambrex Edinburgh, and Stephen Delaney, Managing Director at Q1 Scientific (a Cambrex Company), share insights on the benefits of outsourcing stability storage and testing.

A pharmaceutical company sought a development and manufacturing partner to assist with an in-licensed product originating from an emerging pharma company.

Review advanced retrosynthetic analysis services and how these tools empower better, more efficient development of innovative small molecule drugs.

Review a case study describing the selection of the optimal solid form of an API designed for pulmonary administration through the pulmonary route.